Zomepirac sodium
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
OBJECTIVE
To examine changes in the prescribing of analgesics after the market entry and subsequent withdrawal of zomepirac…
A large, computerized database derived from Medicaid claims was used to evaluate the risk of allergy and/or anaphylaxis…
Zomepirac sodium (ZS) (5 mg/kg i.v.) was used to evaluate the effects of preischemia cyclooxygenase inhibition on CBF (as…
The nonsteroidal anti-inflammatory drugs are widely used in the United States and are a frequent cause of cutaneous reactions…
Our purpose was to compare the analgesic efficacy of single oral doses of ibuprofen, zomepirac, aspirin, and placebo in severe…
Abstract: Five healthy male human subjects were administered 200 mg oral solution doses of zomepirac‐14C sodium. Plasma and urine…
Abstract: In a single‐dose, double‐blind crossover study in 40 patients with chronic pain due to advanced cancer, zomepirac…
Zomepirac sodium (ZS) is an orally active, nonnarcotic, analgesic agent. The disposition and pharmacokinetics of zomepirac (Z…